| antibody e. |
see prozone.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|---|
| antibody h. |
a measure of the mean survival time of antibody molecules following their formation, usually expressed as the time required to eliminate 50 per cent of a known quantity of immunoglobulin from the animal body. Half-life varies from one immunoglobulin class to another.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| antibody i. |
deficiency in immunity mediated by B lymphocytes, marked by hypo- or dysgammaglobulinemia and recurrent bacterial otitis media and sinopulmonary infections. For a list of disorders of this type, see table.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| antibody s. |
a method of determining the presence and amount of anti-HLA antibodies in the serum of a potential allograft recipient: aliquots of the recipient's serum are mixed with a panel of leukocytes from well-characterized cell donors and complement is added. Reaction between the recipient's pre-existing antibody and specific antigen in the donor cells leads to cell lysis; the percentage of different cells lysed provides a rough measure of the sensitization of the recipient (referred to as the panel reactive antibody).
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| antibody-dependent cell-mediated c. |
lysis of target cells coated with antibody by effector cells with cytolytic activity and Fc receptors, including K cells, macrophages, and granulocytes; a form of type II hypersensitivity reaction. ADCC involves binding of the effector cell by means of Fc receptors which bind to the Fc portion of the IgG molecule. Lysis of the target cell is extracellular, requires direct cell-to-cell contact, and does not involve complement.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|